Cargando…
The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. MET...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219478/ https://www.ncbi.nlm.nih.gov/pubmed/24289252 http://dx.doi.org/10.1186/1471-2407-13-563 |
_version_ | 1782342591753224192 |
---|---|
author | Lohberger, Birgit Stuendl, Nicole Wolf, Elisabeth Liegl-Atzwanger, Bernadette Leithner, Andreas Rinner, Beate |
author_facet | Lohberger, Birgit Stuendl, Nicole Wolf, Elisabeth Liegl-Atzwanger, Bernadette Leithner, Andreas Rinner, Beate |
author_sort | Lohberger, Birgit |
collection | PubMed |
description | BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. METHODS: After the establishment of the novel myxofibrosarcoma cell lines MUG-Myx1, cells were characterized using short tandem repeat (STR), copy number variation (CNV), and genotype/loss-of-heterozygosity (LOH) analyses. The growth behaviour of the cells was analyzed with the xCELLigence system and an MTS assay. The tumourigenicity of MUG-Myx1 was proved in NOD/SCID mice. Additionally, a stem-like cell population with high enzymatic activity of aldehyde dehydrogenase 1 (ALDH1(high)) was isolated for the first time from myxofibrosarcoma cells using the Aldefluor® assay followed by FACS analysis. RESULTS: The frozen primary parental tumour tissue and the MUG-Myx1 cell line showed the same STR profile at the markers D3S1358, TH01, D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta D, Amelogenin, D8S1179, TPOX, and FGY. Typically, myxofibrosarcoma gain and/or amplification was mapped to 7p21.3-q31.1, q31.1-q31.33, q33-q36.2, p21.3, p21.2, p14.1-q11.23, q31.33-q33, p21.2-p14.1, q11.23-q21.3, q36.2-q36.3, which, respectively are known to harbour tumour-associated genes, including TIF, BRAF, MLL3, SMO, and MET. Typically an LOH for myxofibrosarcoma on chr5 q21 was found. In addition, MUG-Myx1 ALDH1(high) cells showed an upregulation of the ABC transporter ABCB1 and ABCG2; higher c-Myc, E-cadherin and SOX-2 expression; and a higher potential for tumourigenicity and proliferation levels. CONCLUSION: The new myxofibrosarcoma cell line MUG-Myx1 was established to enrich the bank of publicly available cell lines, with respect to providing comprehensive genetic and epigenetic characterization. Furthermore, because of their tumourigenicity, the cell line is also suitable for in vivo experiments. |
format | Online Article Text |
id | pubmed-4219478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42194782014-11-05 The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity Lohberger, Birgit Stuendl, Nicole Wolf, Elisabeth Liegl-Atzwanger, Bernadette Leithner, Andreas Rinner, Beate BMC Cancer Research Article BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. METHODS: After the establishment of the novel myxofibrosarcoma cell lines MUG-Myx1, cells were characterized using short tandem repeat (STR), copy number variation (CNV), and genotype/loss-of-heterozygosity (LOH) analyses. The growth behaviour of the cells was analyzed with the xCELLigence system and an MTS assay. The tumourigenicity of MUG-Myx1 was proved in NOD/SCID mice. Additionally, a stem-like cell population with high enzymatic activity of aldehyde dehydrogenase 1 (ALDH1(high)) was isolated for the first time from myxofibrosarcoma cells using the Aldefluor® assay followed by FACS analysis. RESULTS: The frozen primary parental tumour tissue and the MUG-Myx1 cell line showed the same STR profile at the markers D3S1358, TH01, D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta D, Amelogenin, D8S1179, TPOX, and FGY. Typically, myxofibrosarcoma gain and/or amplification was mapped to 7p21.3-q31.1, q31.1-q31.33, q33-q36.2, p21.3, p21.2, p14.1-q11.23, q31.33-q33, p21.2-p14.1, q11.23-q21.3, q36.2-q36.3, which, respectively are known to harbour tumour-associated genes, including TIF, BRAF, MLL3, SMO, and MET. Typically an LOH for myxofibrosarcoma on chr5 q21 was found. In addition, MUG-Myx1 ALDH1(high) cells showed an upregulation of the ABC transporter ABCB1 and ABCG2; higher c-Myc, E-cadherin and SOX-2 expression; and a higher potential for tumourigenicity and proliferation levels. CONCLUSION: The new myxofibrosarcoma cell line MUG-Myx1 was established to enrich the bank of publicly available cell lines, with respect to providing comprehensive genetic and epigenetic characterization. Furthermore, because of their tumourigenicity, the cell line is also suitable for in vivo experiments. BioMed Central 2013-12-01 /pmc/articles/PMC4219478/ /pubmed/24289252 http://dx.doi.org/10.1186/1471-2407-13-563 Text en Copyright © 2013 Lohberger et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lohberger, Birgit Stuendl, Nicole Wolf, Elisabeth Liegl-Atzwanger, Bernadette Leithner, Andreas Rinner, Beate The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title | The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title_full | The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title_fullStr | The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title_full_unstemmed | The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title_short | The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
title_sort | novel myxofibrosarcoma cell line mug-myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219478/ https://www.ncbi.nlm.nih.gov/pubmed/24289252 http://dx.doi.org/10.1186/1471-2407-13-563 |
work_keys_str_mv | AT lohbergerbirgit thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT stuendlnicole thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT wolfelisabeth thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT lieglatzwangerbernadette thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT leithnerandreas thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT rinnerbeate thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT lohbergerbirgit novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT stuendlnicole novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT wolfelisabeth novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT lieglatzwangerbernadette novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT leithnerandreas novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity AT rinnerbeate novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity |